MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
-$257K
Net Income
-$27,560K
Net Profit Margin
10723.74%
EPS
-$0.73
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Collaboration revenue
-257
1,248
8,659
8,513
Research and development
22,512
19,300
25,283
22,507
General and administrative
6,004
6,535
6,215
6,993
Total operating expenses
28,516
25,835
31,498
29,500
Loss from operations
-28,773
-24,587
-22,839
-20,987
Interest income
1,256
1,539
2,214
2,485
Change in fair value of long-term investments
0
-
0
1,292
Other income (expense), net
35
-1
-2
-70
Total other income, net
1,291
1,538
2,212
1,123
Net loss before provision for income taxes
-27,482
-23,049
-20,627
-19,864
Provision for income taxes
0
10
-234
44
Net loss
-27,482
-23,059
-20,393
-19,908
Unrealized loss on available-for-sale marketable securities
-78
-304
-1
-249
Comprehensive loss
-27,560
-23,363
-20,394
-20,157
Basic EPS
-0.73
-0.61
-0.55
-0.54
Diluted EPS
-0.73
-0.61
-0.55
-0.54
Basic Average Shares
37,658,250
37,581,094
37,349,449
37,156,979
Diluted Average Shares
37,658,250
37,581,094
37,349,449
37,156,979
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$27,560K
(-36.73%↓ Y/Y)
Net loss
-$27,482K
(-38.05%↓ Y/Y)
Unrealized loss on
available-for-sale marketable...
-$78K
(68.67%↑ Y/Y)
Interest income
$1,256K
(-49.46%↓ Y/Y)
Other income
(expense), net
$35K
(150.00%↑ Y/Y)
Net loss before
provision for income taxes
-$27,482K
(-38.35%↓ Y/Y)
Total other income,
net
$1,291K
(14.96%↑ Y/Y)
Loss from operations
-$28,773K
(-37.10%↓ Y/Y)
Total operating
expenses
$28,516K
(-3.34%↓ Y/Y)
Collaboration revenue
-$257K
(-103.02%↓ Y/Y)
Research and development
$22,512K
(0.02%↑ Y/Y)
General and
administrative
$6,004K
(-14.14%↓ Y/Y)
Buy us a coffee
Metagenomi Therapeutics, Inc. (MGX)
Metagenomi Therapeutics, Inc. (MGX)